companydata.dkcompanydata.dk

DNASENSE ApS: Financial statements 2021

CVR: 36036869

Source: annual report 2021, Danish Business Authority

01/10/202030/09/2021

DNASENSE ApS (CVR 36036869) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 3,039,679 and a net result of DKK 77,939 compared with DKK -1,081,586 the year before. That is an increase of 110.2% compared with the year before. Equity in the 2021 report amounted to DKK -14,970. The company had 5 employees in the financial year.

Gross Profit
DKK 3,039,679
Profit/Loss
DKK 77,939
Equity
DKK -14,970
Total Assets
DKK 1,230,834
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-3 mio.78 t.-15 t.5
2020-1.4 mio.-1.1 mio.-93 t.5
2019-3.4 mio.679 t.1.3 mio.4
2018-2.3 mio.524 t.910 t.2
2017-1.8 mio.673 t.886 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like DNASENSE ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

DNASENSE ApS: The 2020 annual report is outFeb 23, 2021

DNASENSE ApS has published its annual report for 2020. Gross profit came to DKK 1,445,856, and the net result was DKK -1,081,586.

About DNASENSE ApS

DNASENSE ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mads Toft Søndergaard. The board consists of Anders Christian Neto de Sousa Grøn (chair), Anders Mohr Christensen, Henrik Bjørn Nielsen and Manoj Nirmal Dadlani. The company is owned by Clinical-Microbiomics A/S. The company has 15 employees (2018). In 2025, the company reported a gross profit of DKK 7,915,337 and a net result of DKK 894,729. Equity in the 2025 report amounted to DKK 1,639,012.

Source: annual report 2025, Danish Business Authority